PP_1170x120_10-25-21

Raj Rai

Fresenius Kabi to buy Akorn for $4.3 billion

Fresenius Kabi to buy Akorn for $4.3 billion

LAKE ZURICH, Ill., and LAKE FOREST, Ill. — Global health care company Fresenius Kabi plans to acquire U.S. prescription and over-the-counter drug maker Akorn for $4.3 billion. Under the deal, announced late Monday, Fresenius Kabi agreed to buy Akorn $34 per share, plus the assume about $450 million of debt. The U.S. headquarters for Akorn

Akorn adds to executive team

LAKE FOREST, Ill. — Akorn Inc. has announced four appointments to its management team, including a new sales and marketing leader. The specialty generic pharmaceutical company said Monday that Jonathan Kafer has been hired as executive vice president of sales and marketing, a newly created position. In the role, he will oversee all commercial functions for Akorn’s business units, as well as play an